Evaluating Clinical Utility of Medical Devices, Diagnostics & Therapeutics with Conjoint Analysis/Clinical Vignettes, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, learn about how conjoint analysis with efficient large sample survey data can inform evidence development plans for medical device, diagnostic and therapeutics companies. The featured speakers will provide an overview of the process of conducting a conjoint analysis study to demonstrate clinical utility to payers and healthcare providers. View a case study that demonstrates how conjoint analysis assessed the clinical utility of a test predicting the risk of kidney disease/decline in Type 2 diabetes mellitus patients.

Register for this webinar as the speakers review clinical utility and describe its importance to payers, physicians, patients and the manufacturers of medical devices, diagnostics/prognostics and therapeutics.

In this webinar, the speakers will discuss the methods used to demonstrate the clinical utility of medical products, and will explain how preference studies, such as conjoint analyses with physician survey data, fit into the armamentarium of techniques used to generate clinical utility evidence. They will provide an overview of conjoint analysis and describe the process of conducting a conjoint analysis study.

The speakers will also present a case study showing how conjoint analysis assessed the clinical utility of a blood-based biomarker test that predicts the risk of kidney disease/decline in Type 2 diabetes mellitus patients. This case study will present typical results of a clinical utility study with conjoint analysis: 1) the relative importance of patient/test attributes for physician monitoring, prescribing and dosing decisions; 2) odds ratios for the impact of low-risk, moderate-risk and high-risk test results on physician decision-making; and 3) value messages supported by the study results.

They will demonstrate that with conjoint analysis they were able to quantify the clinically and statistically significant impact of the novel blood-based biomarker test on patient management decisions, and objectively demonstrate the test’s value to physicians across a range of patient types.

Register for this webinar as the speakers review clinical utility and describe its importance to payers, physicians, patients and the manufacturers of medical devices, diagnostics/prognostics and therapeutics.

Join experts from Veranex, Thomas Goss, Senior Vice President, Commercial Strategy and Market Access; and Lauren Fusfeld, Director, Commercial Strategy and Market Access, for the live webinar on Monday, November 21, 2022, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Evaluating Clinical Utility of Medical Devices, Diagnostics & Therapeutics with Conjoint Analysis/Clinical Vignettes.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:
Ayesha Rashid
Tel: +1 (416) 977-6555 x272
Email: arashid@xtalks.com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ayesha Rashid
Xtalks
+1 (416) 977-6555 x272
Email >
Visit website